SEC Filing Summary: ChromaDex Corporation (CDXC)
Business Context and Reporting Period
This Form 8-K, dated March 9, 2022, serves as a current report for ChromaDex Corporation. The filing announces the release of financial results for the fourth quarter and the full year ended December 31, 2021. The report also references a corporate presentation made available to investors on the same date.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the attached press release (Exhibit 99.1) and investor presentation (Exhibit 99.2), which are referenced but not included in the filing text itself.
Material Changes
The filing text does not provide specific data regarding material changes compared to prior periods. It solely confirms the issuance of the earnings announcement for the period ended December 31, 2021.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, and specific risk factors are contained within the attached exhibits (Exhibit 99.1 and Exhibit 99.2). The filing text notes that the information in these exhibits is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2021 financial results.
- Examine Exhibit 99.2 (Investor Presentation) for management outlook and strategic updates.
- Verify the trading symbol (CDXC) and exchange (Nasdaq Capital Market) for accurate market data correlation.
- Confirm the filing date of March 9, 2022, to ensure alignment with the reported earnings period.